Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-25 @ 9:31 PM
Study NCT ID:
NCT00788151
Status:
COMPLETED
Last Update Posted:
2022-04-05
First Post:
2008-11-07
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years
Sponsor:
Sanofi Pasteur, a Sanofi Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CYD24
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None